Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
... standard of care, or SOC) for 12 weeks at dose levels of 200 mg or 400 mg twice daily (bid), each with ... SOC alone. Patients who have undetectable levels of virus at weeks 4 and 12 will be randomized to ... proportion of patients who achieve undetectable levels of virus at week 12 ( c omplete E arly V ...VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...Progenitor Cell Therapy Appoints VP of Manufacturing Operations
... company or its industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements ... reasonable, it cannot guarantee future results, levels of activity, performance, or achievements. ...Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
... with metastatic carcinoid tumors. Elevated levels of serotonin contribute to the gastrointestinal ... currently available therapy. Up to four dose levels may be evaluated in a serial ascending fashion. ... enzyme in the synthesis of serotonin. Excessive levels of serotonin have been implicated in symptoms ...Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... that endogenous luteinizing hormone (LH) levels do not affect ongoing pregnancy rates in women ... The observed number of follicles, serum estradiol levels and number of oocytes indicated a relatively high ... on the day of hCG and median serum estradiol levels of 10,019 and 10,221 pmol/L, respectively.(6) ...VIA Pharmaceuticals' DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...Genomatica Produces Pure BDO From Natural Sugars
... of BDO production and concentration can reach levels consistent with commercial goals; and finally, to ... demonstrated the ability to produce BDO at high levels from sucrose as well as from xylose, a ... microbes can produce, approaching the commercial levels needed to manufacture large volumes of BDO at ...Graphene yields secrets to its extraordinary properties
... equally spaced energy levels. In graphene these levels are known to be unevenly spaced because of the ... non-uniform spacing among discrete energy levels that form when the material is exposed to ... high-resolution map of the distribution of energy levels in graphene. In contrast to metals and other ...InterMune Reports First Quarter 2009 Financial Results and Business Highlights
... of patients in the last two dosage cohorts had levels of virus in their blood below the limit of ... 14 days experienced a median reduction in viral levels of -4.8 to -5.2 Log10 IU/mL in the last two ... days of dosing, the mean reduction in viral load levels was 0.6 log10 greater with combination treatment ...Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
... foreign exchange rates would remain at budgeted levels throughout the year, Late-Stage backlog would ... In addition, the company maintained staffing levels to support expected increases in revenue ... trends in the pharmaceutical industry, levels of industry research and development spending, ...Athera Signs Agreements With German and UK Distributors for New Cardiovascular Biomarker
... Products and Oxford Biosystems." High levels of IgM antibodies against phosphorylcholine ... However, in 2008 data indicating that low anti-PC levels predict an increased risk of CVD were presented. ... is based on phosphorylcholine (PC) and low levels of antibodies to PC in human serum have been ...VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...VIA Pharmaceuticals Complies With NASDAQ Rules
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...Publication of Shire plc's Annual Report 2008
... and reimbursement at satisfactory levels for such products may adversely affect revenues ... included: target net revenue and defined levels of revenue growth; target sales and ... at all doses and increased target enzyme activity levels in a majority of patients. Shire has rights to ...VIA Pharmaceuticals Secures Financing Up to $10.0 Million
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
... engineered to express proteins at high levels and have been shown to express better than ... promoter routinely expresses proteins at higher levels comparable to T7 pET vectors and works in any E. ... vectors, including data demonstrating the high levels of protein expression compared to pET vectors, ...Spectral announces 2008 financial results
... Assay (EAA(TM)), used for measuring endotoxin levels in the blood, the combination has demonstrated a ... identify patients with elevated endotoxin levels and to guide endotoxin reducing ... 2008 to use EAA(TM) to measure endotoxin levels during the enrolment of patients in a ...Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
... outcome will be assessed by measuring C-peptide levels (a surrogate of endogenous insulin secretion) and ... insulin required to control blood glucose levels by inhibiting the destruction of beta cells. The ... production, patients must monitor their glucose levels frequently and administer insulin regularly to ...FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
... ADA. The A1C test measures average blood glucose levels over the past two- to three-month period. ... meal plan, Apidra(R) is proven to help reduce A1C levels in adults and children (4 years and older) with ... time each day. You must test your blood sugar levels while using insulin such as Lantus(R). The ...VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291
... factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements ... and which could materially affect actual results, levels of activity, performance or achievements. ...VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
... (GWAS) of fasting and postprandial triglyceride levels was performed as part of the Heredity and ... cholesterol) levels, high HDL (good cholesterol) levels and protection against heart disease as evidenced by decreased levels of coronary artery calcification. The ...New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
... for Optimizing Marketing Staff levels to Drive Growth." Data from this study were ... including: -- Staffing and productivity levels utilized across healthcare business models -- Growth and profit margin levels across biopharma portfolios -- Strategic and ...